Original Research

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

Cui Q, Hu Y, Ma D, Liu H

Drug Design, Development and Therapy 2021, 15:339-347

Published Date: 27 January 2021